A multicenter, prospective, observational, real-world cohort study evaluating the efficacy and safety of lecanemab combined with rivastigmine transdermal patch compared to lecanemab monotherapy in early Alzheimer's disease. (ChiCTR) - Oct 16, 2026 - P=N/A | N=364 | Not yet recruiting | Sponsor: Fujian Medical University Union Hospital; Fujian Medical University Union Hospital
New trial • Alzheimer's Disease • CNS Disorders
|